Icade SA
PAR:ICAD
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
19.91
35.92
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Icade SA
You don't have any saved screeners yet
Hello, and welcome to this call on the Icade Results as of March 30, 2021. My name is Rosie, and I'll be your coordinator for today's event. Please note, this call is being recorded. [Operator Instructions] I will now hand you over to Olivier Wigniolle, CEO; and Victoire Aubry, CFO, to begin today's conference. Thank you.
So good morning, everyone, Olivier Wigniolle speaking. So thanks for joining this call today. So I'm going to present our Q1 results with Victoire Aubry, our CFO. And the presentation will be followed by the Q&A session. So I hope you're all fine and safe. Personally, I'm just out of my COVID, so not a great experience, but I'm fine. So we have disclosed our revenues for Q1 2021 on Friday afternoon after our general meeting. So maybe before to start the presentation, let me remind you what is the sanitary situation in France as of today. So as you know, we have a third lockdown in France that has started at the beginning of April and that is supposed to end the 3rd of May, subject to further notice by the French government. So let's say, like this, it's a smooth lockdown, quite comparable to the one that we had during last November. So the main topic, the main consequence for Icade is that we don't have a shutdown for our construction side, so it's clearly good news. On the other hand, with the lockdown, it's difficult, for sure, to organize a visit for office premises. And our marketing suites for residential schemes are closed by request of the government. But the impact on residential is limited as we have a full digital marketing process for our residential scheme. As you know, in France, the vaccination is now an ongoing concern, reaching its cruising speed with more than 20% of the French population that have received the first vaccine injection, so probably good news by the end of the summer 2021. So just to summarize, it is clear that sanitary situation is not over and back to normal. But let's say, that we are now used to it and that Icade teams have learned how to manage such a situation. So let's go to Slide 4 now to start the presentation. So what are the key points for our Q1 figures in term of revenues. So headline revenues at the end of March, they grew by plus 44% compared to 2020, amounting to EUR 392.5 million. So for sure, Q1 2020 was a special period with the beginning of the pandemic at the end of February 2020. And 1 month of Q1 2020 was already impacted by the crisis. Therefore, I think it is also quite relevant to compare our 2021 figure with Q1 2019. And it represents also a significant increase of plus 30%. Our global figure of EUR 392.5 million is a blended figure. So if we go more into the detail for our investment portfolio, our revenues amount to EUR 171.5 million, up by plus 1.5%. For the office property portfolio, I would like to highlight the good dynamic leasing activity, more than 65,000 square meters were signed or renewed during Q1. And the rental income is close to stable, minus 0.6% compared to Q1 2020. And we had a very high level of rent collection during Q1 2021, above 97%. I would have also to highlight that, as announced earlier in February, for the preliminary agreements, we have also completed 2 asset disposals for a total of EUR 320 million, so it's a significant amount, plus 6% above NAV at the end of 2020. And also, I think interesting to highlight that it's in line with NAV at the end of 2019. And just to remind you also that rotation within our office portfolio is one of our top priorities for 2021. Regarding the Healthcare division, for sure, the asset class is still more than resilient with revenue that are up by plus 4.7%. And we are still focused on the growth of the portfolio and the Pan-European expansion. So in this respect, the first acquisition that we have made in Spain, it's a good news. It's the fourth country for Icade Santé after France, Italy and Germany. So for Icade Promotion, our development subsidiary, thanks to the very strong demand for residential in France, the figure of this quarter are really strong. Revenues amount to EUR 317.4 million, up by plus 115% at the end of March compared to 2020. Maybe, also, a very interesting figure for new orders, up plus 126%. And just to remind you that Icade Promotion, our development subsidiary, was the activity that was the most impacted by the COVID-19 crisis in 2020 because of the shutdown of our construction side for 2.5 months. So as I said, in 2021, even with a certain lockdown, our construction side are still functioning. And therefore, we will be able to book 100% of our revenues. One word about our liability side. We have kept on optimizing the company's funding structure and very favorable condition. So we have issued, beginning of January, a tenure EUR 600 million bond with an annual coupon of 0.62%, which is an historical low cost for a 10-year debt at Icade. And we have used this fund mainly to optimize our liabilities, early redemption of the bond maturing in 2022. That was with a coupon of 1.87% and also the early reduction of a bond maturing in April 2021 with a coupon of 2.25%. Important also to highlight that our next significant debt maturity is now only 2023. So clearly, we have absolutely no liquidity concern. So my view is that our Q1 figures reflect, I think, the resilience of our business model with 3 different activities. And the Icade team are now, more than ever, fully mobilized to go to the crisis and to cope with the COVID-19 crisis. I will come back to guidance and dividend with the conclusion. So if you go to Slide 5, so you have the detail of the figures that I have commented with the split between offices, Healthcare and Development. So now, Victoire, the floor is yours for more detail and comments on our activity.
Thank you, Olivier and good morning, everybody. So to recall, in this world, let me elaborate on the operational performance of our business lines. I'm now on Slide 6 and share with you the main KPIs of our Office Investment division. Let's talk first about leasing activity, 2 figures reflecting the dynamic asset management job done during the first part of the year. First, a total achievement of 65,000 square meters signed or renewed since January 1. Thanks to continued proactive crisis management with our tenants, at the end of March, more than 85% of the 2021 break options were estimated to have been prevented or covered by the signing of new leases. In addition, the collection rate, nearing 96%, reflecting also as we put forward a lot in 2020 the solidity of our tenant base. I want also to underline the resilient rental income despite the health crisis and the shrinking rental market aligned with our expectation, around EUR 94 million, EUR 93.5 million, to be precise, down minus 0.6% on a reported basis. It remains solid especially under the current circumstances. We have a like-for-like 2% decrease due to a slightly positive indexation and some expected departure. It's fair to assume that it should keep declining this year. On the one hand, we are confident on our capability to hold our existing tenants, and on our other hand, it may be more challenging to attract new tenants in 2021. Another evidence of what I'm saying regarding the solidity of our tenant profile is another financial KPI key for us, credit default rate that stands now below 1%. Talking about occupancy rate for this division, it's quite stable at 90.4%, minus 1.4 points on a like-for-like basis. This indicator illustrates also the resilience of our office in this investment portfolio. Let me highlight that no significant tenant departure has been notified in Q1. Second topic I would like to highlight, development pipeline and investments, a very active quarter also with 2 major deliveries representing more than 80,000 square meters. Firstly, Icade handed over Technip Energy's new headquarters, Origine, nearly 51,000 square meters of office space in Nanterre, a very attractive and dynamic location. This important investment, nearly EUR 450 million, illustrate our office investment expertise in developing major office projects. With its hybrid timber concrete structure, the Origine project is also at the apex of Icade's low carbon expertise and, hence, achieving the highest levels of French and international environmental certification, fully in line with our low carbon strategy. At this stage, 80% of the new space is leased, and Icade's team, of course, are fully committed to secure total floor area. The second main delivery from this quarter, the new Latécoère headquarter, a 13,000 square meters building in Toulouse that is fully rented. Including those 2 completion projects to be completed by the end of 2021 are 63% pre-let.Last topic I want to share with you regarding the Office division, asset rotation that has actively resumed. Olivier has previously referred to the disposal we made. We had announced, during our annual results, the preliminary agreements as part of the 2021 disposal plan and the resumption of opportunistic disposal of Core and Core+ assets in the Office portfolio. And we are happy today to confirm those 2 transactions totaling more than EUR 320 million. First, sale of the Loire building in Villejuif Val-de-Marne on April 18, 2021, to an institutional investor from the insurance sector. Built in 2010, this building had a floor area of around 20,000 square meter and is fully let with the French bank LCM. The second one, sale of the Millénaire 1 building in Paris on April 21, 2021, to a real estate investment fund manager by Brookfield Asset Management, a world leader in real estate asset management. Built in 2007, this 29,000 square building located in the Millénaire Business Park in the 19 district of Paris is fully let to 2 first-rate tenants from the financial sector. These sales were completed at the plus 6% premium to 2020 NAV, meaning by that plus 6% regarding the global asset value in 2020. They are the first milestone of EUR 500 million to EUR 600 million objective of the disposal plan for 2021, a volume in line with the average we have done during the last 3 years. Beside in terms of active acquisitions, we just signed a value-add opportunistic operation in Nanterre, right next to La Défense in an area we know very well. This asset offer high potential for value creation through its future redevelopment. All in all, we can say that our Office Investment division remains very agile to meet the challenges of the current market environment. Going forward, On Page 7 is a focus on the Healthcare division. As we said earlier, this year and the year before, the impact of the COVID-19 crisis has been very limited on this noncyclical asset class portfolio. Let me remind that health care operators are strongly supported by government measures since the beginning of the crisis and that those measures have been extended until June 2021. The figures consume very favorable indicators and continued expansion. Let me talk about our gross rental income first or GRI. This quarter amounted to EUR 78 million, up plus 4.7% on a reported basis, fueled by acquisition carried out in 2020 in France, but also in Italy and Germany. On a like-for-like basis, revenue are up 0.4%. In terms of geographical breakdown front, gross rental income at EUR 72.3 million, plus 2.3%. International, gross rental income increased to EUR 5.7 million. Occupancy rate is still at 100% as well as rent collection with no impact at all of the crisis. Furthermore, we benefit also from solid portfolio of tenants that are long-term committed warm at 7.3 years. It is stable compared to December 2020. On average, it's stood at 6.6 years as far as assets located in France are concerned, 16 years abroad. The investment market momentum remains strong in this division too, and we continue to be active in our view. Growing in France and abroad is one of our objectives this year by maintaining a steady number of projects, sales and leasebacks or off-plan acquisitions as well as [ diversifying ] or partnerships. In France, our investment in Q1 amounted to almost EUR 44 million. Let me illustrate with the 18.6% operation for the acquisition of Les Dentellières facility located in Valenciennes, operator, Elsan. And in addition, we also invest nearly EUR 20 million in the French development pipeline. In Europe, Icade lead our first acquisition in Spain with a preliminary agreement with the Amavir Group to acquire 2 nursing homes in Spain for EUR 22 million, including duties. This is a milestone in the Healthcare Property Investment division's international expansion strategy and brings the amount invested outside France in the end of 2018 to nearly EUR 750 million. All these metrics confirm Icade's Healthcare attractiveness to continue our rigorous growth of the business line and are good news for the future this year and beyond. Now I'm talking about the third business line. I'm on Slide 8, Property Development or development subsidiary for external clients. As Olivier said previously, the business recovery is here, as we expected, has largely put forward in 2020. The revenues and operational sales indicators were heavily impacted by the crisis and the step-up construction seats during 2.5 months. As highlighted on this slide, valuation compared to Q1 2020 are quite dynamic when compared to 2019 also. This performance is not really a question of catch-up. Q1 2021 economic revenue grows by 128% year-to-year to nearly EUR 250 million, but also plus 56% growth versus 2019. Several positive impacts can explain this strong outturn this quarter. Construction projects progressed faster than in previous year over the same period. But also sales of projects nearing completion, which typically have a strong positive impact as revenue is recognized using the POC method, percentage of completion method, where also substantial. Thus, revenue from the Residential segment rose by 136%, had EUR 207 million in Q1 2021 versus EUR 87 million in Q1 2020. Concerning the Office segment, revenue grows by 92% this Q1 at EUR 41 million. If we look at order on Q1, the indicators are also well oriented, plus 126% in term of new order, plus 96% in value terms. I want to mention the strong progression of the notary sales, too. As you can see, they jump by 92% versus Q1 2020 and plus 5% versus Q1 2019. This growth partially explains the rise of the Residential segment I just mentioned, in addition, with a sharp year-on-year increase in construction starts, plus 38%. Now looking at leading indicators that remain well oriented confirming growth potential, a backlog of EUR 1.4 billion, down slightly compared to December 2020, resulting from accelerating revenue recognition in Q1 '21. On the 12-rolling-month basis, the trend showed solid performance with the backlog up by nearly 10%, driven by the Residential segment, plus 16%. An additional potential of revenues of EUR 2.2 billion deriving from the residential portfolio that we do control through option of preliminary agreements. It comprised 10,902 units. And this potential revenues, excluding taxes, represent an increase of plus 4% compared to December 2020. In total, Icade Promotion potential revenues stand at EUR 6.8 billion in the 5 coming years. On top of that, we noticed last year that the market profile of investor had evolved during the year with institutional ones back to the residential market. The appetite is confirmed on the third quarter again, with institutional investors representing more than 50% of the order. Regarding this matter, let me mention, as an example, Athlètes Village project in Saint-Ouen that is totaling 314 units, business premises, retail units, residential services and a student residence. Last but not least, Icade is also very ambitious in terms of low-carbon construction and aims at being best-in-class regarding that topic. Through the creation in early 2021 of its subsidiary, Urbain des Bois, specializing in low-carbon construction and own personalization, Icade Promotion is stepping up its involvement in timber construction, one of the driver of its low-carbon strategy. The objective to realize EUR 100 million revenues end of 2025. To conclude on that activity and on the back of a demand that remains structurally high, we are ready to address the challenges and are in line with our 2025 ambition road map.
Thank you very much, Victoire. So let's go now to Slide 9 to conclude this presentation on our Q1 2021 revenues. So as we did say in February, we have very clear priorities for 2021, and we are sticking to that. Just let me recall them. The first one is with respect to the Office portfolio, so it's to focus on portfolio rotation and value creation deriving from the development pipeline. We have completed 2 schemes during the Q1 2021. Origine and Latécoère, as Victoire said, both of them were 100% fully let. We will have another one in June 2021 in Nanterre, fully let to Groupama. And the last one will be [ presque ] 20,000 square meters of offices that will be completed Q4 2021, still not pre-let but ongoing discussion. On Healthcare, we are focused on further growth and international expansion. And we are working on the preparation of liquidity even as we -- again, as we did say. For development subsidiary, you could have seen the, I think, the interesting figures for Q1. And it's clearly our priorities for development, our development subsidiaries to increase revenues, but also to achieve higher margin. Our CSR priorities is clearly the acceleration of our low-carbon strategy. And it's called low carbon by card, and we have presented the detail of that in February. And our fifth priority is the operational implementation of our purpose in our different activities. I think it's also an important topic for the team. So the first quarter in development figures, I think is -- I think, in our view, is quite solid and confirm, I think, the resilience of our business model, which is a mixed business model with 3 different activities. In addition, clearly, the beginning of the year has been very active for Icade, especially in terms of new letting for offices. You have seen the figures. As I said, the completion of 2 schemes, the asset disposal more than EUR 320 million for the growth in Italy and Germany, first acquisition in Spain for Healthcare, and clearly, a development business which is quite well oriented. On top, we have been able to continue to optimize our balance sheet in terms of financial condition. So it is clear that even if the sanitary crisis is not over, it is clear that probably 2021 still [ italicizes ] a challenging year. We are very confident that we will achieve the targets and objectives that we have announced for 2021. And therefore, with regard to our guidance, we do confirm the guidance that the 2021 group net cash flow per share is expected to grow by around 3%, excluding the impact of 2021 disposal. And also, I think it was important to give a clear view on the evolution of the dividend. And the 2021 dividend for Icade is expected also to increase by plus 3%, which represents a payout ratio close to 83%, and the distribution of part of the capital gain deriving from disposal. So that's the end of the presentation of our Q1 revenue. And now Victoire and I are ready to answer your questions.
[Operator Instructions] Our first question comes from the line of Florent Laroche-Joubert from ODDO BHF.
So Olivier, Victoire, so I would have 2 questions, if I may. So first question, so you have been able to tell us that you have secured 5% of -- in addition, of break option. So that means that there are still 15% of precaution to be fixed to suite. So could you please give us maybe more color on your confidence to secure them during the year or during the next month? So that would be my first question. And my second question will be on the [ S. Square ] So you have told at your annual results that you were in discussion for the potential acquisition of EUR 1 billion of assets. So we are being able to see that you have done a EUR 70 million of investment in Q1. So could you please maybe give us an update on the transaction, the amount of transactions that you are looking?
Okay. So for your 2 questions, maybe start with the second. We are actually assessing a rolling volume of investment under review close to EUR 1 billion. And you know what is the volume of our acquisition plan, it was EUR 2.5 billion between in '19 and 2022. We have already closed 60% of that at the end of 2020. So we -- I think we have a sufficient pipeline to reach our growth ambition. Nevertheless, market is quite competitive, and we try to -- really, to stick to our investment criteria in a world for Healthcare assets where you have a lot of new competitors coming to the market. But we are clearly, and I will say that even the pipeline is growing because due to the increase of valuation, I think that more and more operating companies are thinking -- some of them are thinking to stick their real estate assets on their balance sheet, but most of them are thinking to outsource their real estate portfolio due to the fact that market conditions are quite favorable for vendor. So we are confident with the fact that we will be able to deliver the acquisition plan, that we will be able to continue the Pan-European expansion that would be maybe to open a new country in 2021. So for your first question about the break option for office building, I will make several comments. The first one is that, the remaining part is -- a large part of that is linked to office building in Lyon fully let to Framatome. And we knew before the beginning of the crisis that they will leave the 2 buildings in Lyon. So -- and even when we did acquire those 2 assets, it was with the AMF transaction in 2017. They had -- Framatome already launched the building of a new headquarter in Lyon. So those 2 buildings will be vacated. And we have already -- we know exactly what we will do with those 2 projects to redevelopment, best location in Lyon, very close to La Part-Dieu station. So it means that the remaining 20% of break option of, we have a little more to secure, but not that much because a large part of that is linked these 2 buildings in Lyon. I will make more -- a general comment on the office letting market transaction. The first one is, I'm sure you have seen the figures released by real estate brokers. So clearly, to move to a new headquarters is not the top priority of most of the corporate in 2021. If you look at the figures for the Paris letting office market, it's minus 30% compared to Q1 2020. So that's the general picture. It's still very difficult to organize a visit of office premises. So that explain the fact that we have a slight decrease of the occupancy rate. So our feeling, our view is that it's better compared to the second part of 2020, the market condition. We have seen more than -- in terms of large transaction, we have seen more large transaction in Q1, 13 compared to 10 in Q1 2020, so it's a bit better. But I think we will have to wait the second part of 2021 before to go back to, let's say, a normal market situation. It's clearly linked to the sanitary situation. As you probably know, corporate are still requested by the French government to do, as much as possible, work from home. So it's still not a normal situation. So we do -- we are, let's say like this, we are quite confident and positive. We have, I think, an interesting discussion on new scheme also, which is something new in terms of relating to the 3 years in advance, but it's clearly not a normal situation. So I think maybe to wait, again, 6 month before to have a normal market leasing activity. It's what we do have in mind for the time being.
The next question comes from the line of Veronique Meertens from Kempen.
Maybe just as a check-up point. So the vacancy rate, as you said, okay, it might be hard to attract new tenants. Can we expect the vacancy rate to not improve over the year and even get a little bit worse as the 2 assets in Lyon will be thrust to the development pipeline? And also, I was curious what you're seeing in terms of reversion rate for the portfolio? And lastly, do you have -- can you elaborate a bit on the long-term dividend strategy? Is the 83% payout ratio something that you want to stick to in the coming years as well?
Okay. Regarding the occupancy rate, as I commented just before, we had a slight decrease. It's minus 1.6 points as I said. It's mainly due to a completion we have done last year at the end of the year, which is not already fully rent. Of course, the teams, the asset management teams are very concentrate on the objective to pursue the occupancy rate of these buildings, which is in Marseille -- in Lyon -- which is in Lyon. And so that is the main reason of the evolution of the occupancy rate regarding the first part of the quarter -- of the year. Of course, there is another impact, which is the completion of Origine, which is already pre-let at a level -- which is already let at a level of 79%. And of course, it is the second main reason of the slight decrease of the occupancy rate. And as I said, one more time, teams are very focused on our ability to complete the occupancy of this building as soon as possible. Regarding your second question, which is about the option we offer this year with the scrip dividend for the 2020 dividend. Of course, so far, the Board decided to propose to give you a global view of the trend of the evolution of the 2021 dividend. It's perhaps a little bit too early to precise if they want to continue to renew this scrip option. But what we can say so far today is that in our point of view in the current context, it's a good option to contribute, for the shareholders to contribute to reinforce the global balance sheet of the company. It should represent this year, if there is a 100% subscription to this option, an additional equity of around EUR 120 million. So clearly, it's a good thing in term of balance sheet management. But as I said, so far, it's a little bit too early to precise if this option will be re-conduct in -- for the 2021 dividend.
Okay. And maybe lastly, on the reversion rate that you expect or see for the office portfolio?
Slightly -- we expect a slightly negative evolution regarding the reversion rate. It's difficult to say, but what we can observe regarding the first part of the year, it's around minus 2%. I don't know if we have additional questions.
Our next question comes from the line of Celine Huynh from Barclays.
I just have 2 questions. The first one would be on the office acquisition that you've done in Nanterre. Can you comment on the rationale and how much you've paid for it? And the second one would be on Icade Promotion. How do the margin profit -- deposit margin compared to 2020 and '19? I appreciate you do not disclose the margin in Q1, but just a brief comment whether it is getting worse or better.
On the format, the rationale for the acquisition of a value-add building, as you know, our job is to recycle the capital in the office portfolio. So it's disposal in order to finance new development or new acquisition. This specific building is located on a location that we really do like. And we really do like it because we do think it's probably one of the best location of the greater Paris area. It's a location that we know perfectly well, where we do have a lot of assets, very close to the Origine project. And the building is, for the time being, fully let to the public tenant that will leave the property probably in 3 years from now. The acquisition has, I think, quite appealing cash-on-cash cap rate, it's close to 6%. And the building that has to be refurbished, to be restructured when the tenant will leave. So it's clearly a value-add opportunity. And that is clearly our job to create value. So for the first 3 years, we will have the cash flow coming from the fact that the building is relet. And for that, we do think we should be able to manage a redevelopment project that should deliver a double-digit higher. So that's the rationale. it's clearly a rotation within the office portfolio.
Sorry, did you see a yield of 6%.
Sorry?
Did you say a yield of...
Around, around, around.
Around 6%. Did you get a discount on it or not?
A discount what?
A discount on what?
On asking price of this asset?
No, no, we are still under the preliminary agreement, so we can't comment too much. But I think it's clearly, I think, an interesting acquisition on a location that we do know perfectly well. We know exactly what are the potential tenants, the rental values and so on. We have really good cooperation with the city of Nanterre, so no clue about the fact that we should be able to get the building permit and so on. So it's a limited transaction of around EUR 60 million. But it's clearly, I think, quite interesting. And maybe we will do some more transaction of that kind during the year if there are interesting opportunities. On margin, I think we can't compare 2021 margin with 2020 due to the fact that -- due to the [indiscernible] margin in 2020, they were close to close to 0 with cash flow in 2020 for Icade Promotion that represented EUR 2.5 million, so more than -- an unusual year for Icade Promotion. So our view is that we should be able to do close to the same level of 2019 on an average midterm trend, which is, is to increase that. So I think the market is there, clearly, so it's -- in term of demand. So in order to be able to achieve the margin, you look at the margin at 2 different levels. You have the level of scheme by scheme, and gross margin should be around 18%. And after that, you have the overall margin at the level of Icade Promotion. And your other question is the volume. As we said, we do think the volume is quite well oriented. And I'm sure you have in mind that the only concern that we have at the level of the market is that the overall volume of building permit that we should be able to get due to the fact that, let's say, like these local authorities are maybe a little bit more reluctant to grant building permits. So the challenge for Icade Promotion is not now. I think we are back right on track at the level of each scheme. It's more a question of volume. You probably have in mind that in 2020, the market -- building permit for the entire market, it was minus 21% compared to 2019. And there is a debate on the French market and with local authorities on the volume of building permit for the time being.And as Victoire said, forward KPIs are well oriented, but we are looking at how the situation is evolving. Maybe you have seen some comments from our colleague, a company [ peer ] that have released their figures 2 weeks ago. They were very concerned about that. We are probably a little bit less concerned due to the fact that the activity of Icade Promotion is mainly concentrated on large scale that are initiated and monitored by local authorities. And therefore, they can't stop them or they can't renegotiate them. But it's clearly a point for the residential market. Again, it's not a question of demand. Demand both from private clients or institutional clients is really strong. So the question is more the supply, and the supply comes from building permits. So -- but it's not a question for us for 2021 or 2022. It's more a question if the trend will follow the -- will remain the same. It's more a question for 2023, 2024. But again, as Victoire said, we are confident with the fact that we will be able to deliver the road map that we have presented at the end of 2018.
The next question comes from the line of Christopher Fremantle from Morgan Stanley.
I had just 2 questions, please. First, on Healthcare. I'm sorry, another question about the liquidity event. How has your view on timing and structure developed since you last talked about this? And if it hasn't changed, when are we likely to learn more about the timing and structure of that liquidity event? And then the second question is on -- just a follow-up on Celine's question on development, you've compared to 2019, which is helpful. Is it fair to assume a similar increase in percentage terms in the quarters to come in 2021 as you have reported in the first quarter? Or is there anything special about the first quarter that would make the comparison with 2019 different for the rest of the year?
Victoire, do you want to answer the 2 questions?
Yes. We can begin with the first one regarding the liquidity event. And for instance, so far, the answer is exactly the same of what we say in February. We are working hard on it. And two, on top -- perhaps more precisely to your question regarding when we will be able to give you more detail, I think mid of the year could be a more favorable condition to give you more detail regarding this liquidity event. But of course, one more time, as we said, it's clearly a job we are working hard on since the beginning of the year. And I hope -- so we will be able to give you more detail in June with our half year results presentation. On the second question regarding following up on development, I think that, as I said, just before, as I highlight, there is an impact of catch-up regarding the figures we have shown in 2021 first quarter. And after saying that, we can expect not such vigorous figure for the next quarter. But in the meantime, we are very confident in saying that there will be a slight increase regarding the 2019 figures. That's what I can give you, what I can say to you this morning.
And for sure, as a principle, we will make for -- especially for H1 result, we'll make the full comparison for sure with 2020, but also with 2019 because we do think that for -- it is also for investment. I think it's more relevant compared to 2019 because, again, 2020 was a very special and specific year.
So a slight increase versus 2019 for the remaining quarters? Have I understood that correctly? Relative to 2019?
Yes, you could take that into account, yes.
Our final question for today comes from the line of Pierre Clouard from Kepler.
Yes. I hope you are both well, especially you, Olivier. So I have 3 questions from my side. Just the first one to come back on the property development. So 50% of your reservation have been realized with institutional investors. Is there a specific buyer there? Can we imagine that the CDC Habitat has been very active in the quarter or not? So this is my first one. The second one is just coming back on the Prairial building in Nanterre. Can you remind us the total acquisition price? Sorry if I missed that. And the last one on disposals. So you realized above EUR 300 million of disposal. So can we imagine more disposals in 2021 or not? Are you thinking about any potential new disposals by the end of the year?
Okay. I will answer all your 3 questions. Now on the first one, it was true that in 2020, CDC Habitat was a very significant buyer on a client for Icade Promotion as it was foremost of the developer in France. It's not exactly the same situation in 2021, much more diversified client base. CDC Habitat has announced that they will try to do the same figures compared to 2020. And they have acquired last year on the French market 60,000 apartments. I don't think they will be able such a volume this year. But for us, it's clearly, we want to diversify our client base and you have more and more institutional clients. And it is also fair to say that the demand from private client is still very strong. The level of mortgages in France, again, a record level, lower level, so strong asset value from private client.
And is it possible to have a breakdown on the investors that bought reservation?
Yes. I don't have it in mind, but we will revert to you this morning. On the second question, so we are under preliminary agreement. So we can't give full detail. But I have mentioned the figure, which is close to EUR 60 million, the building we have acquired in Nanterre.And in terms of disposal, as Victoire said, and as we said during our investor presentation in November, after a very significant volume in 2019, more than EUR 1.1 billion, no disposal in 2020. And what we do have in mind is to have a disposable volume close to, let's say, like this normal level on a midterm trend, which is between EUR 500 million to EUR 600 million. So it means that we should be able to announce other disposal in 2020. Again, the rationale for that is to recycle the capital and to raise capital gain to be reinvested, increasing the office development pipeline because we still have a significant office development pipeline, the growth of Icade Santé and, as you know, also the fact that we want to decrease our LTV ratio by the end of 2023. So we will use the proceeds at the disposal to address the 3 topics I have mentioned.
Pierre-Emmanuel, you have, on Page 6, the breakdown of housing or the buy-type of consumers, if you want to have an analysis.
Page 6 Of the press release.
Yes. Yes.
Yes. But I want to have more details, in terms of as an institutional investor, I just wanted to know what are the main buyers?
You always want more detail.
I know. I know.
We will revert to you. Thank you very much, all of you, for attending this call. And again, if you have any furthermore detailed question, do not hesitate to contact Anne-Sophie or Victoire. We will revert to you as quickly as possible. Thank you very much. Goodbye.
Thank you for joining today's conference. You may now disconnect. Thank you.